Keywords: lonza, invest, 200m, chinese, operations, swiss, biotechnology

Lonza to invest $200M in Chinese operations

Article | 17 April 2006

Swiss biotechnology group Lonza says it will invest $200.0 million to enhance its existing production operations in Nansha Guangzhou, China. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lonza

Go to company listing

Related Drugs

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing